https://doi.org/10.7490/f1000research.1117847.1
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
254
 
downloads
22
CITE
How to cite this poster:
Seth A, Lee H, Park C et al. Synergistic Combination of Vasculature Disrupting Agent with TLR7/8 Agonist: Promising Strategy for Melanoma Therapy [version 1; not peer reviewed]. F1000Research 2020, 9:272 (poster) (https://doi.org/10.7490/f1000research.1117847.1)
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.

Synergistic Combination of Vasculature Disrupting Agent with TLR7/8 Agonist: Promising Strategy for Melanoma Therapy

Anushree Seth, Hyunseung Lee, Cheongsoo Park, Joo-Yong Lee, Kwan Soo Hong1
Author Affiliations
  • Metrics
  • 254 Views
  • 22 Downloads
 
Browse by related subjects
Published 19 Apr 2020

Synergistic Combination of Vasculature Disrupting Agent with TLR7/8 Agonist: Promising Strategy for Melanoma Therapy

[version 1; not peer reviewed]

Anushree Seth, Hyunseung Lee, Cheongsoo Park, Joo-Yong Lee, Kwan Soo Hong1
Author Affiliations
1 Korea Basic Science Institute, South Korea
Presented at
14th Annual Meeting of the Association for Cancer Immunotherapy
Abstract
Competing Interests

No competing interests were disclosed

Keywords
combination therapy, dendritic cells, nanoparticle, TLR7/8 agonist, vasculature disruption
Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.